Stratos Wealth Partners LTD. increased its stake in Cigna Corporation (NYSE:CI) by 14.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 2,172 shares of the health services provider’s stock after buying an additional 279 shares during the period. Stratos Wealth Partners LTD.’s holdings in Cigna Corporation were worth $364,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Private Trust Co. NA bought a new position in Cigna Corporation during the first quarter valued at $205,000. Guardian Life Insurance Co. of America boosted its position in Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after buying an additional 7 shares during the period. Asset Advisors Corp boosted its position in Cigna Corporation by 7.3% in the first quarter. Asset Advisors Corp now owns 29,845 shares of the health services provider’s stock valued at $4,372,000 after buying an additional 2,025 shares during the period. Wetherby Asset Management Inc. boosted its position in Cigna Corporation by 3.5% in the first quarter. Wetherby Asset Management Inc. now owns 4,159 shares of the health services provider’s stock valued at $609,000 after buying an additional 140 shares during the period. Finally, First Manhattan Co. boosted its position in Cigna Corporation by 4.5% in the first quarter. First Manhattan Co. now owns 9,910 shares of the health services provider’s stock valued at $1,291,000 after buying an additional 424 shares during the period. Institutional investors own 86.91% of the company’s stock.

Shares of Cigna Corporation (CI) opened at 175.63 on Wednesday. The stock has a market cap of $44.96 billion, a price-to-earnings ratio of 23.45 and a beta of 0.46. The stock’s 50 day moving average price is $171.37 and its 200-day moving average price is $158.04. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $178.50.

Cigna Corporation (NYSE:CI) last released its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 7.46%. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.98 EPS. On average, equities research analysts forecast that Cigna Corporation will post $9.95 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Cigna Corporation (NYSE:CI) Shares Bought by Stratos Wealth Partners LTD.” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/08/09/cigna-corporation-nyseci-shares-bought-by-stratos-wealth-partners-ltd.html.

CI has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $175.00 price objective on the stock in a research report on Tuesday, April 25th. Credit Suisse Group started coverage on Cigna Corporation in a research note on Monday, June 12th. They issued an “outperform” rating and a $185.00 target price for the company. Jefferies Group LLC reaffirmed a “buy” rating and issued a $183.00 target price (up previously from $178.00) on shares of Cigna Corporation in a research note on Friday, May 5th. Stifel Nicolaus upped their target price on Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, May 5th. Finally, Oppenheimer Holdings, Inc. upped their target price on Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, June 15th. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. Cigna Corporation has an average rating of “Buy” and an average price target of $180.06.

In related news, VP Mary T. Hoeltzel sold 500 shares of the business’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total transaction of $83,350.00. Following the completion of the transaction, the vice president now owns 2,449 shares in the company, valued at approximately $408,248.30. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Matthew G. Manders sold 24,357 shares of the business’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $175.01, for a total value of $4,262,718.57. Following the transaction, the insider now owns 46,256 shares of the company’s stock, valued at approximately $8,095,262.56. The disclosure for this sale can be found here. In the last three months, insiders have sold 219,558 shares of company stock worth $37,135,665. Corporate insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.